Back
Enzon Pharmaceuticals, Inc. 10K Form
Sell
45
ENZN
Enzon Pharmaceuticals, Inc.
Last Price:
$0.07
Seasonality Move:
-3.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | ENZN/Enzon Pharmaceuticals, Inc. Quarterly |
| 2023-11-09 | 10Q | ENZN/Enzon Pharmaceuticals, Inc. Quarterly |
| 2023-08-07 | 10Q | ENZN/Enzon Pharmaceuticals, Inc. Quarterly |
| 2023-05-05 | 10Q | ENZN/Enzon Pharmaceuticals, Inc. Quarterly |
| 2022-11-09 | 10Q | ENZN/Enzon Pharmaceuticals, Inc. Quarterly |
| 2022-08-04 | 10Q | ENZN/Enzon Pharmaceuticals, Inc. Quarterly |
Receive ENZN News And Ratings
See the #1 stock for the next 7 days that we like better than ENZN
ENZN Financial Statistics
Sales & Book Value
| Annual Sales: | $26K |
|---|---|
| Cash Flow: | $-1M |
| Price / Cash Flow: | 23.17 |
| Annual Sales: | $-0.01 |
| Price / Book: | 9.54 |
Profitability
| EPS (TTM): | -0.04970 |
|---|---|
| Net Income (TTM): | $-2.4M |
| Gross Margin: | $0 |
| Return on Equity: | -5.37% |
| Return on Assets: | -5.28% |
Enzon Pharmaceuticals, Inc. Earnings Forecast
Key Enzon Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 39 years for ENZN is 0.00%.
-
The Selling, General & Administrative Expenses for ENZN have been equal to 5,203.85% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of ENZN is 2,992.31% of Total Revenues.
-
Per Share Earnings over the last 39 years have been positive in 16 years.
Enzon Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ENZN |
| CUSIP: | 293904 |
| Website: | enzon.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 80.86 |
| Quick Ratio: | 80.1 |
Price-to-Earnings
| Trailing P/E Ratio: | 96.1 |
|---|---|
| Forward P/E Ratio: | 0 |
ENZN Technical Analysis vs Fundamental Analysis
Sell
45
Enzon Pharmaceuticals, Inc. (ENZN)
is a Sell
Is Enzon Pharmaceuticals, Inc. a Buy or a Sell?
-
Enzon Pharmaceuticals, Inc. stock is rated a SellThe current Enzon Pharmaceuticals, Inc. [ENZN] share price is $0.07. The Score for ENZN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.